Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update.
This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNFalpha) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.